Helica · Pharmacogenomics, plainly stated
Helica reads the DNA file you already have and tells you which prescriptions to flag for your doctor. Cited. Conversational. Reanalyzed every quarter.
Intermediate metabolizer
Your CYP2C19 enzyme processes some drugs more slowly. The most common one to flag: clopidogrel (Plavix) — it may not work as well for you.
Affected medications
A real finding, on a real genome.
A pitch in three sentences
Most genome reports are a static dump you read once and file away.
Helica is a conversation with the file you already paid for.
And it’s reanalyzed every quarter, as the science evolves.
A worked example
We test every line of copy against this question: would Helica actually surface this for a real customer, in language they can use?
01 — The patient view
“Your ABCG2 transporter is impaired. CPIC recommends limiting rosuvastatin to ≤20 mg/day.” Not poor function, not diplotype, not jargon you have to translate before you can act on it.
02 — The clinical view
Generate a one-page PDF for your prescriber on demand. Genotype, phenotype, CPIC level, affected medications, citation. Nothing else. Designed to be the first PGx document a primary-care physician actually reads.
03 — The cited line
The card shows the source — CPIC’s 2022 statin guideline — and the pipeline that called it: PharmCAT 3.0.1. Click through to the underlying paper. We don’t ask you to trust us. We ask you to verify us.
Poor function
Your ABCG2 transporter is impaired. CPIC recommends limiting rosuvastatin to ≤20 mg/day; consider an alternative statin if higher dose is required.
Affected medications
Poor function
Your ABCG2 transporter is impaired. CPIC recommends limiting rosuvastatin to ≤20 mg/day; consider an alternative statin if higher dose is required.
Affected medications
Why a subscription
additional findings on the same genome over a few-year window — because the science around your variants changes constantly. We re-run your file every quarter and email you the diff.
PMC7338758 · Re-analysis of clinical exome sequencing data
What Helica covers
We don’t re-sequence. We read the file you already have at the depth the existing consumer products skipped.
Pricing
Reanalysis is the actual subscription value. Findings get reclassified. CPIC guidelines update. New PGx genes hit clinical-grade evidence. Your file gets re-run every quarter.
The product for most adults
$24/mo billed annually
Free tier available at launch.
Free tier · No credit card
Start with the file you already have. Two real findings on your own genome — a PGx flag and a carrier call — before you decide if it's worth subscribing.
Helica is informational and not a substitute for medical advice. Discuss any change to your medications with a licensed prescriber. Findings are based on validated, peer-reviewed sources, including CPIC, ClinVar, and the PGS Catalog. Polygenic risk scores are useful estimates, not diagnoses.